Matthew D Linnik - CSO & Exec VP Research, La Jolla Pharmaceutical Co

As of December 27, 2006


Matthew D Linnik Net Worth

  • Net worth is estimated to be at least $23.24K
  • Owns at least 1,300 units of La Jolla Pharmaceutical Co stock
  • Sold an estimated value of $60.84K in the last 3 years at La Jolla Pharmaceutical Co

Matthew D Linnik Trading

  • Largest sale of shares was 5,365 units , worth over $15.5K on December 27, 2006
  • In total has made about 10 transactions over 3 years
  • Usually trades in December, with the busiest year in 2006 and 2005
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

La Jolla Pharmaceutical Co Insider Trading

  • The most recent transaction was 24,500 units bought on December 6, 2021 by David A Ramsay worth over $91.99K
  • In the last 18 years, insiders at La Jolla Pharmaceutical Co sold an estimated value of $19.48M and bought an estimated value of $254.96M
  • The most active traders are Lakhmir Chawla, Chief Medical Officer,  Michael Hearne, Chief Financial Officer,  and James Rolke, Chief Scientific Officer
  • Insider trading is most common in May, with the busiest year in 2019

LA JOLLA PHARMACEUTICAL CO Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1